Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 1
1964 1
1980 4
1981 4
1982 4
1983 6
1984 4
1985 6
1986 6
1987 2
1988 11
1989 8
1990 7
1991 9
1992 8
1993 14
1994 11
1995 13
1996 13
1997 29
1998 21
1999 32
2000 35
2001 25
2002 41
2003 73
2004 81
2005 72
2006 85
2007 107
2008 108
2009 148
2010 154
2011 210
2012 225
2013 294
2014 354
2015 392
2016 424
2017 460
2018 494
2019 569
2020 750
2021 837
2022 932
2023 956
2024 1096
2025 927
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,132 results

Results by year

Filters applied: . Clear all
Page 1
Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance.
Lei G, Sun M, Cheng J, Ye R, Lu Z, Horbath A, Huo D, Wu S, Alapati A, Aggarwal S, Xu Z, Mao C, Yan Y, Yao J, Li Q, Chen X, Lee H, Zhuang L, Jiang D, Pataer A, Roth JA, Navin N, Koong AC, You MJ, Lin SH, Gan B. Lei G, et al. Among authors: jiang d. Cancer Cell. 2025 Jun 9;43(6):1076-1092.e5. doi: 10.1016/j.ccell.2025.03.031. Epub 2025 Apr 10. Cancer Cell. 2025. PMID: 40215978 Free article.
Evans syndrome revisited.
Jiang D, Kuter DJ. Jiang D, et al. Blood Rev. 2025 Jul 24:101322. doi: 10.1016/j.blre.2025.101322. Online ahead of print. Blood Rev. 2025. PMID: 40717001 Review.
Acquired resistance in cancer: towards targeted therapeutic strategies.
Soragni A, Knudsen ES, O'Connor TN, Tognon CE, Tyner JW, Gini B, Kim D, Bivona TG, Zang X, Witkiewicz AK, Goodrich DW, Jiang D, Gammon ST, Willey CD, Boutros PC, Sandulache VC, Osman AA, Myers JN, Mehla K, Singh PK, Chan KS, Gao H, Marathe H; National Cancer Institute (NCI) Acquired Resistance to Therapy Network (ARTNet). Soragni A, et al. Among authors: jiang d. Nat Rev Cancer. 2025 Aug;25(8):613-633. doi: 10.1038/s41568-025-00824-9. Epub 2025 Jun 3. Nat Rev Cancer. 2025. PMID: 40461793 Free PMC article. Review.
Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk: The OPT-BIRISK Randomized Clinical Trial.
Li Y, Li J, Wang B, Jing Q, Zeng Y, Hou A, Wang Z, Liu A, Zhang J, Zhang Y, Zhang P, Jiang D, Liu B, Fan J, Zhang J, Li L, Su G, Yang M, Jiang W, Qu P, Zeng H, Li L, Qiu M, Ru L, Chen S, Zhou Y, Qiao S, Stone GW, Angiolillo DJ, Han Y; OPT-BIRISK Investigators. Li Y, et al. Among authors: jiang d. JAMA Cardiol. 2024 Jun 1;9(6):523-531. doi: 10.1001/jamacardio.2024.0534. JAMA Cardiol. 2024. PMID: 38630489 Free PMC article. Clinical Trial.
In Science Journals.
Vignieri S, Lavine MS, Yeston JS, Suleymanov Y, Olingy C, Ash C, Matsiko A, Smith HJ, Alderton G, Nusinovich Y, Funk MA, Seale M, Jiang D, Ross SH, Hallberg DL, Aldenderfer M, Foley JF, Shilatifard A. Vignieri S, et al. Among authors: jiang d. Science. 2024 Feb 16;383(6684):715-717. doi: 10.1126/science.ado6282. Epub 2024 Feb 15. Science. 2024. PMID: 38359142
In Science Journals.
Uzogara E, Yeston JS, Szuromi P, Stern P, Wong W, Jiang D, Berry BJ, Kelly PN, Maroso M, Lopez B, Lavine MS, Scanlon ST. Uzogara E, et al. Among authors: jiang d. Science. 2024 Feb 2;383(6682):491-493. doi: 10.1126/science.ado3601. Epub 2024 Feb 1. Science. 2024. PMID: 38300998
In Other Journals.
Ray LB, Vignieri S, Smith J, Seale M, Wible B, Jiang D, Stajic J. Ray LB, et al. Among authors: jiang d. Science. 2025 Sep 11;389(6765):1105. doi: 10.1126/science.aec1443. Epub 2025 Sep 11. Science. 2025. PMID: 40934326
9,132 results